Literature DB >> 22985966

Directed evolution of the forkhead-associated domain to generate anti-phosphospecific reagents by phage display.

Kritika Pershad1, Karolina Wypisniak, Brian K Kay.   

Abstract

While affinity reagents are valuable tools for monitoring protein phosphorylation and studying signaling events in cells, generating them through immunization of animals with phosphopeptides is expensive, laborious, and time-consuming. An attractive alternative is to use protein evolution techniques and isolate new anti-phosphopeptide binding specificities from a library of variants of a phosphopeptide-binding domain. To explore this strategy, we attempted to display on the surface of bacteriophage M13 the N-terminal Forkhead-associated (FHA1) domain of yeast Rad53p, which is a naturally occurring phosphothreonine (pT)-binding domain, and found it to be nonfunctional due to misfolding in the bacterial periplasm. To overcome this limitation, we constructed a library of FHA1 variants by mutagenic PCR and isolated functional variants after three rounds of affinity selection with its pT peptide ligand. A hydrophobic residue at position 34 in the β1 strand was discovered to be essential for phage display of a functional FHA1 domain. Additionally, by heating the phage library to 50°C prior to affinity selection with its cognate pT peptide, we identified a variant (G2) that was ~8°C more thermally stable than the wild-type domain. Using G2 as a scaffold, we constructed phage-displayed libraries of FHA1 variants and affinity selected for variants that bound selectively to five pT peptides. These reagents are renewable and have high protein yields (~20-25mg/L), when expressed in Escherichia coli. Thus, we have changed the specificity of the FHA1 domain and demonstrated that engineering phosphopeptide-binding domains is an attractive avenue for generating new anti-phosphopeptide binding specificities in vitro by phage display.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985966      PMCID: PMC3488158          DOI: 10.1016/j.jmb.2012.09.006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  44 in total

1.  The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms.

Authors:  D Durocher; I A Taylor; D Sarbassova; L F Haire; S L Westcott; S P Jackson; S J Smerdon; M B Yaffe
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

Review 2.  The FHA domain.

Authors:  Daniel Durocher; Stephen P Jackson
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

3.  The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.

Authors:  P Cohen
Journal:  Eur J Biochem       Date:  2001-10

4.  Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2.

Authors:  Jiejin Li; Brandi L Williams; Lesley F Haire; Michal Goldberg; Erik Wilker; Daniel Durocher; Michael B Yaffe; Stephen P Jackson; Stephen J Smerdon
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

Review 5.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 6.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

7.  FHA: a signal transduction domain with diverse specificity and function.

Authors:  Ming Daw Tsai
Journal:  Structure       Date:  2002-07       Impact factor: 5.006

8.  The DsbA signal sequence directs efficient, cotranslational export of passenger proteins to the Escherichia coli periplasm via the signal recognition particle pathway.

Authors:  Clark F Schierle; Mehmet Berkmen; Damon Huber; Carol Kumamoto; Dana Boyd; Jon Beckwith
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

Review 9.  Phosphotyrosine-binding domains in signal transduction.

Authors:  Michael B Yaffe
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 10.  SH2 and PTB domains in tyrosine kinase signaling.

Authors:  Joseph Schlessinger; Mark A Lemmon
Journal:  Sci STKE       Date:  2003-07-15
View more
  5 in total

1.  Generating FN3-Based Affinity Reagents Through Phage Display.

Authors:  Kevin Gorman; Jennifer McGinnis; Brian Kay
Journal:  Curr Protoc Chem Biol       Date:  2018-06-07

2.  A comparison of phosphospecific affinity reagents reveals the utility of recombinant Forkhead-associated domains in recognizing phosphothreonine-containing peptides.

Authors:  Leon A Venegas; Kritika Pershad; Oluwadamilola Bankole; Noman Shah; Brian K Kay
Journal:  N Biotechnol       Date:  2016-01-06       Impact factor: 5.079

3.  Nature-inspired design of motif-specific antibody scaffolds.

Authors:  James T Koerber; Nathan D Thomsen; Brett T Hannigan; William F Degrado; James A Wells
Journal:  Nat Biotechnol       Date:  2013-08-18       Impact factor: 54.908

4.  FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein.

Authors:  Christina J Miller; Jennifer E McGinnis; Michael J Martinez; Guangli Wang; Jian Zhou; Erica Simmons; Tohti Amet; Sanofar J Abdeen; James W Van Huysse; Ronald R Bowsher; Brian K Kay
Journal:  N Biotechnol       Date:  2021-02-05       Impact factor: 6.490

5.  A Recombinant Affinity Reagent Specific for a Phosphoepitope of Akt1.

Authors:  Jennifer E McGinnis; Leon A Venegas; Hector Lopez; Brian K Kay
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.